{"id":227625,"title":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-19","captureTimestamp":"2025-04-19T05:29:21.011000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html?wbdisable=true","snippet":"Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca Skip to main content Skip to \"About government\" Skip to section menu Language selection…","rawSnapshotUrl":"/api/snapshots/raw/227625","browseUrl":"https://replay.healtharchive.ca/job-1/20250419052921/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html?wbdisable=true#ha_snapshot=227625","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}